Konoplev Sergej, Medeiros L Jeffrey, Bueso-Ramos Carlos E, Jorgensen Jeffrey L, Lin Pei
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Am J Clin Pathol. 2005 Sep;124(3):414-20. doi: 10.1309/3G1X-DX0D-VHBN-VKB4.
We retrospectively reviewed the immunophenotypic profile of 75 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) analyzed by flow cytometry. All patients had monoclonal IgM (median, 2,100 mg/dL [21 g/L]) in serum and were considered clinically to have WM. The neoplastic cells, in all cases, expressed monoclonal immunoglobulin light chain (k, 55; l, 20) and CD19, and every case assessed was positive for CD20 (n=68) and CD52 (n=60). The results for other antigens assessed in decreasing frequency of positivity were as follows: surface IgM (26/28 [93%]), CD79b (11/13 [85%]), CD11c (13/16 [81%]), CD25 (5/7 [71%]), CD23 (17/28 [61%]), CD38 (24/50 [48%]), FMC7 (11/29 [38%]), CD22 (4/12 [33%]), CD5 (3/65 [5%]), and CD10 (1/38 [3%]). These results show that the immunophenotype of LPL/WM is variable and overlaps with other B-cell lymphoproliferative disorders. CD23, usually of dim intensity, and CD11c are expressed commonly in LPL/WM. Rare CD5+ and CD10+ cases of LPL/WM also exist.
我们回顾性分析了75例经流式细胞术检测的淋巴浆细胞淋巴瘤/华氏巨球蛋白血症(LPL/WM)的免疫表型特征。所有患者血清中均有单克隆IgM(中位数为2,100mg/dL[21g/L]),临床上均诊断为WM。所有病例中的肿瘤细胞均表达单克隆免疫球蛋白轻链(κ,55例;λ,20例)和CD19,且所有评估病例的CD20(n = 68)和CD52(n = 60)均为阳性。其他评估抗原的阳性频率由高到低依次为:表面IgM(26/28[93%])、CD79b(11/13[85%])、CD11c(13/16[81%])、CD25(5/7[71%])、CD23(17/28[61%])、CD38(24/50[48%])、FMC7(11/29[38%])、CD22(4/12[33%])、CD5(3/65[5%])和CD10(1/38[3%])。这些结果表明,LPL/WM的免疫表型具有多样性,且与其他B细胞淋巴增殖性疾病存在重叠。CD23通常呈弱表达,CD11c在LPL/WM中普遍表达。也存在罕见的CD5+和CD10+的LPL/WM病例。